Back to search

Aristotle University Of Thessaloniki (AUTH)

Mechanistic characterization of MSC1-mediated tumor suppression in colorectal cancer: an integrative systems biology and experimental approach

Abstract

dc:description

Mesenchymal stem cells (MSCs) are promising candidates for cell-based cancer therapies due to their immunomodulatory properties, tumor-homing capacity, and low immunogenicity, yet their role in colorectal cancer (CRC) remains controversial. The mesenchymal stem cells type 1 (MSC1) phenotype, a pro-inflammatory and tumor-suppressive state of MSCs induced by short-term and low-dose lipopolysaccharide (LPS) activation via Toll-like Receptor 4 (TLR4), has emerged as a promising therapeutic model, but is poorly characterized, and its effects in CRC are unexplored. In this study, the tumor-suppressive mechanisms of MSC1 were mapped and their effects on CRC were evaluated using integrated bioinformatics and in vitro approaches. A high-confidence protein-protein interaction network (PPI) downstream of TLR4 activation in Wharton’s jelly-derived MSCs (WJ-MSCs) was constructed, through which key enriched signaling pathways, transcriptional regulators, and a novel anti-cancer secretome were revealed. Functional and transcriptional enrichment analyses identified six key tumor-suppressive mechanisms of MSC1: (i) metabolic reprogramming via enhanced glucose and lipid uptake, phosphoinositide signaling, and membrane/protein recycling, (ii) enhanced antioxidant defenses, including Son of Sevenless (SOS) signaling and the cystine/glutamate antiporter (system xc⁻), (iii) extracellular matrix (ECM) stabilization and laminin-111–integrin–mediated adhesion and migration, (iv) anti-cancer secretome with direct inhibitory effects, (v) regulation of cell survival and inhibition of transformation into a more tumor-permissive phenotype via balanced proliferation, apoptosis, and epigenetic signaling, and (vi) controlled pro-inflammatory signaling with anti-inflammatory feedback. Additionally, migration- and adhesion-related interaction sequences in laminin-111 were identified as being targeted by cAMP-dependent Protein Kinase A (PKA), Protein Kinase C (PKC), and Casein Kinase 2 (CKII) through experimentally observed and predicted phosphorylation events. MSC1 function in CRC was validated using in vitro co-cultures with CRC cell lines. Significant suppression of cancer cell proliferation and metabolism was demonstrated, providing the first experimental evidence of a tumor-suppressive role for MSC1 in this context. These findings elucidate the mechanisms of MSC1 in CRC and establish a foundation for the development of MSC1-based therapies.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Galliou, Panagiota-Angeliki
  • Γάλλιου, Παναγιώτα-Αγγελική

Subjects

dc:subject × 32

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60902

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Galliou, Panagiota-Angeliki; Γάλλιου, Παναγιώτα-Αγγελική. Mechanistic characterization of MSC1-mediated tumor suppression in colorectal cancer: an integrative systems biology and experimental approach. Aristotle University Of Thessaloniki (AUTH), 2026. http://hdl.handle.net/10442/hedi/60902